Greater Than Sevenfold Return on Investment for a Comprehensive Patient Blood Management Program With Equivalent or Improved Outcomes

Anesth Analg. 2024 Jun 1;138(6):1345-1348. doi: 10.1213/ANE.0000000000006862. Epub 2024 Mar 25.

Authors

Steven M Frank¹, Nadia B Hensley¹, Ananda J Thomas¹, Clarita G Dawson¹, Linda M S Resar², John A Ulatowski³, Elizabeth P Crowe³

Affiliations

¹ From the Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
² Department of Medicine (Hematology), Oncology, Pathology, Center for Bloodless Medicine and Surgery, Institute for Cellular Engineering, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
³ Department of Pathology (Transfusion Medicine), The Johns Hopkins Medical Institutions, Baltimore, Maryland.

PMID: 38530909
DOI: 10.1213/ANE.0000000000006862

No abstract available

MeSH terms

Blood Transfusion* / economics
Cost-Benefit Analysis*
Humans
Treatment Outcome